FN1 and familial pancreatic carcinoma: Immunohistochemical staining of mouse tumors showed that the combination of the two drugs promoted apoptosis reduced the proliferation of pancreatic cancer cells, and decreased the activation of PSCs, as indicated by the reduced expression of the activation marker α‐SMA and lower levels of fibrotic proteins such as collagen‐1 and fibronectin.